BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 21891797)

  • 21. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
    Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy.
    Khan M; Pahan K; Singh AK; Singh I
    J Neurochem; 1998 Jul; 71(1):78-87. PubMed ID: 9648853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.
    Netik A; Forss-Petter S; Holzinger A; Molzer B; Unterrainer G; Berger J
    Hum Mol Genet; 1999 May; 8(5):907-13. PubMed ID: 10196381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy.
    Khan M; Singh J; Gilg AG; Uto T; Singh I
    J Lipid Res; 2010 Jul; 51(7):1685-95. PubMed ID: 20173212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABCD2 is a direct target of β-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapy.
    Park CY; Kim HS; Jang J; Lee H; Lee JS; Yoo JE; Lee DR; Kim DW
    PLoS One; 2013; 8(2):e56242. PubMed ID: 23437103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibitor upregulates peroxisomal fatty acid oxidation and inhibits apoptotic cell death in abcd1-deficient glial cells.
    Singh J; Khan M; Pujol A; Baarine M; Singh I
    PLoS One; 2013; 8(7):e70712. PubMed ID: 23923017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.
    Baarine M; Andréoletti P; Athias A; Nury T; Zarrouk A; Ragot K; Vejux A; Riedinger JM; Kattan Z; Bessede G; Trompier D; Savary S; Cherkaoui-Malki M; Lizard G
    Neuroscience; 2012 Jun; 213():1-18. PubMed ID: 22521832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy.
    Hartley MD; Kirkemo LL; Banerji T; Scanlan TS
    Endocrinology; 2017 May; 158(5):1328-1338. PubMed ID: 28200172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy.
    Unterrainer G; Molzer B; Forss-Petter S; Berger J
    Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy.
    Raas Q; van de Beek MC; Forss-Petter S; Dijkstra IM; Deschiffart A; Freshner BC; Stevenson TJ; Jaspers YR; Nagtzaam L; Wanders RJ; van Weeghel M; Engelen-Lee JY; Engelen M; Eichler F; Berger J; Bonkowsky JL; Kemp S
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Very-long-chain fatty acid metabolism in adrenoleukodystrophy protein-deficient mice.
    Yamada T; Shinnoh N; Kondo A; Uchiyama A; Shimozawa N; Kira J; Kobayashi T
    Cell Biochem Biophys; 2000; 32 Spring():239-46. PubMed ID: 11330052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiling and Imaging of Phospholipids in Brains of Abcd1-Deficient Mice.
    Hama K; Fujiwara Y; Morita M; Yamazaki F; Nakashima Y; Takei S; Takashima S; Setou M; Shimozawa N; Imanaka T; Yokoyama K
    Lipids; 2018 Jan; 53(1):85-102. PubMed ID: 29469952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation.
    van Roermund CW; Visser WF; Ijlst L; Waterham HR; Wanders RJ
    Biochim Biophys Acta; 2011 Mar; 1811(3):148-52. PubMed ID: 21145416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis.
    Buda A; Forss-Petter S; Hua R; Jaspers Y; Lassnig M; Waidhofer-Söllner P; Kemp S; Kim P; Weinhofer I; Berger J
    Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders.
    Villoria-González A; Zierfuss B; Parzer P; Heuböck E; Zujovic V; Waidhofer-Söllner P; Ponleitner M; Rommer P; Göpfert J; Forss-Petter S; Berger J; Weinhofer I
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9-mediated knockout of Abcd1 and Abcd2 genes in BV-2 cells: novel microglial models for X-linked Adrenoleukodystrophy.
    Raas Q; Gondcaille C; Hamon Y; Leoni V; Caccia C; Ménétrier F; Lizard G; Trompier D; Savary S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):704-714. PubMed ID: 30769094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy.
    Schlüter A; Espinosa L; Fourcade S; Galino J; López E; Ilieva E; Morató L; Asheuer M; Cook T; McLaren A; Reid J; Kelly F; Bates S; Aubourg P; Galea E; Pujol A
    Hum Mol Genet; 2012 Mar; 21(5):1062-77. PubMed ID: 22095690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adrenoleukodystrophy: structure and function of ALDP, and intracellular behavior of mutant ALDP with naturally occurring missense mutations].
    Takahashi N; Morita M; Imanaka T
    Yakugaku Zasshi; 2007 Jan; 127(1):163-72. PubMed ID: 17202797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
    Weinhofer I; Forss-Petter S; Kunze M; Zigman M; Berger J
    FEBS Lett; 2005 Oct; 579(25):5512-6. PubMed ID: 16213491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
    Kemp S; Wanders RJ
    Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.